AMAG Pharmaceuticals Inc (AMAG) - Financial and Strategic SWOT Analysis Review

September 2020 | 50 pages | ID: AAAA5F9D752EN
GlobalData

Abstracts

AMAG Pharmaceuticals Inc (AMAG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

AMAG Pharmaceuticals Inc (AMAG) develops and commercializes specialty pharmaceutical products with focus on maternal health, anemia management and cancer supportive care. It develops and markets products used to reduce the risk of preterm birth in women with a single baby who have a history of singleton spontaneous preterm birth; and products for the treatment of iron deficiency anemia (IDA) in adult patients who have intolerance to oral iron and chronic kidney diseases. AMAG also provides services related to the collection, processing and storage of umbilical cord blood stem cell and cord tissue units. The company offers its products through direct sales force and a network of distributors. AMAG is headquartered in Waltham, Massachusetts, the US.

AMAG Pharmaceuticals Inc Key Recent Developments

Aug 06,2020: AMAG Pharmaceuticals announces second quarter 2020 financial results and provides corporate update
Jun 12,2020: AMAG Pharmaceuticals to lay off 35 workers at Waltham, Massachusetts site
Jun 11,2020: AMAG Pharmaceuticals announces leadership changes
May 12,2020: AMAG Pharmaceuticals to lay off 32 workers at Waltham, Massachusetts site
May 11,2020: AMAG Pharmaceuticals announces first quarter 2020 financial results and provides corporate update

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

AMAG Pharmaceuticals Inc - Key Facts
AMAG Pharmaceuticals Inc - Key Employees
AMAG Pharmaceuticals Inc - Key Employee Biographies
AMAG Pharmaceuticals Inc - Major Products and Services
AMAG Pharmaceuticals Inc - History
AMAG Pharmaceuticals Inc - Company Statement
AMAG Pharmaceuticals Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
AMAG Pharmaceuticals Inc - Business Description
AMAG Pharmaceuticals Inc - SWOT Analysis
SWOT Analysis - Overview
AMAG Pharmaceuticals Inc - Strengths
AMAG Pharmaceuticals Inc - Weaknesses
AMAG Pharmaceuticals Inc - Opportunities
AMAG Pharmaceuticals Inc - Threats
AMAG Pharmaceuticals Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

AMAG Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
AMAG Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
AMAG Pharmaceuticals Inc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Aug 06, 2020: AMAG Pharmaceuticals announces second quarter 2020 financial results and provides corporate update
Jun 12, 2020: AMAG Pharmaceuticals to lay off 35 workers at Waltham, Massachusetts site
Jun 11, 2020: AMAG Pharmaceuticals announces leadership changes
May 12, 2020: AMAG Pharmaceuticals to lay off 32 workers at Waltham, Massachusetts site
May 11, 2020: AMAG Pharmaceuticals announces first quarter 2020 financial results and provides corporate update
Apr 28, 2020: AMAG Pharmaceuticals appoints Scott Myers as president and chief executive officer
Apr 16, 2020: AMAG Pharmaceuticals provides COVID-19 company update
Mar 04, 2020: AMAG Pharmaceuticals announces changes to medical development organization
Mar 04, 2020: AMAG Pharmaceuticals reports fourth quarter and full year 2019 financial results and provides corporate update
Jan 09, 2020: AMAG Pharmaceuticals announces leadership transition, results of strategic review to unlock shareholder value and financial update

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

AMAG Pharmaceuticals Inc, Key Facts
AMAG Pharmaceuticals Inc, Key Employees
AMAG Pharmaceuticals Inc, Key Employee Biographies
AMAG Pharmaceuticals Inc, Major Products and Services
AMAG Pharmaceuticals Inc, History
AMAG Pharmaceuticals Inc, Other Locations
AMAG Pharmaceuticals Inc, Subsidiaries
AMAG Pharmaceuticals Inc, Key Competitors
AMAG Pharmaceuticals Inc, Ratios based on current share price
AMAG Pharmaceuticals Inc, Annual Ratios
AMAG Pharmaceuticals Inc, Annual Ratios (Cont...1)
AMAG Pharmaceuticals Inc, Annual Ratios (Cont...2)
AMAG Pharmaceuticals Inc, Interim Ratios
AMAG Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
AMAG Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
AMAG Pharmaceuticals Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

AMAG Pharmaceuticals Inc, Performance Chart (2015 - 2019)
AMAG Pharmaceuticals Inc, Ratio Charts
AMAG Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
AMAG Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

COMPANIES MENTIONED

Slayback Pharma LLC
Sanofi-Aventis US LLC
Keryx Biopharmaceuticals Inc
Fresenius Medical Care North America
American Regent Laboratories, Inc.
AMAG Securities Corporation
AMAG Pharmaceuticals Canada Corporation
AMAG Europe Ltd
Allergan Ltd